VIMTA LABS Financial Statement Analysis
|
||
|
The Revenues of VIMTA LABS have increased by 19.19% YoY .
The Earnings Per Share (EPS) of VIMTA LABS has decreased by -42.21 % YoY. |
||
VIMTA LABS Last 5 Annual Financial Results
[BOM: 524394|NSE : VIMTALABS]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹344 Cr | ₹289 Cr | ₹315 Cr | ₹276 Cr | ₹209 Cr |
| Operating Expenses | ₹73 Cr | ₹59 Cr | ₹72 Cr | ₹78 Cr | ₹58 Cr |
| Expenses | ₹222 Cr | ₹195 Cr | ₹222 Cr | ₹196 Cr | ₹156 Cr |
| Operating Profit (Excl OI) | ₹122 Cr | ₹94 Cr | ₹94 Cr | ₹80 Cr | ₹53 Cr |
| Other Income | ₹4.24 Cr | ₹3.71 Cr | ₹3.47 Cr | ₹1.45 Cr | ₹0.81 Cr |
| Interest | ₹1.90 Cr | ₹2.10 Cr | ₹2.64 Cr | ₹1.50 Cr | ₹2.17 Cr |
| Depreciation | ₹35 Cr | ₹33 Cr | ₹31 Cr | ₹23 Cr | ₹23 Cr |
| Profit Before Tax | ₹89 Cr | ₹63 Cr | ₹64 Cr | ₹55 Cr | ₹28 Cr |
| Profit After Tax | ₹67 Cr | ₹49 Cr | ₹47 Cr | ₹41 Cr | ₹21 Cr |
| Earnings Per Share (Rs) | ₹17.35 | ₹30.02 | ₹22.02 | ₹21.37 | ₹18.57 |
| PAT Margin (%) | 19.03 | 19.41 | 16.91 | 15.01 | 14.88 |
| ROE(%) | 18.87 | 19.65 | 16.78 | 18.73 | 19.32 |
| ROCE(%) | 24.81 | 25.23 | 20.55 | 24.25 | 23.85 |
| Total Debt/Equity(x) | 0.01 | 0.02 | 0.06 | 0.05 | 0.08 |
Key Financials |
||
| Market Cap | : | ₹ 2,325.3 Cr |
| Revenue (TTM) | : | ₹ 407.3 Cr |
| Net Profit(TTM) | : | ₹ 77.5 Cr |
| EPS (TTM) | : | ₹ 17.3 |
| P/E (TTM) | : | 30.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VIMTA LABS | 1.7% | 6.1% | 9.5% |
| SAGILITY | NA | -10.8% | 3.2% |
| SYNGENE INTERNATIONAL | 4.4% | -5.8% | -31.3% |
| PRIME FOCUS | -0.7% | -21.9% | 106.6% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | -0.6% | 4.7% | -8.3% |
| INDEGENE | 0.2% | -4.4% | -11.1% |
| NESCO | -4.5% | -14.8% | 18.2% |
| LATENT VIEW ANALYTICS | -3.9% | -4.8% | -25.8% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.3% | 22.1% | 33.3% |
VIMTA LABS Revenues
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 19.19 % |
| 5 Yr CAGR | 13.26 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹344 Cr | 19.19 | |
| Mar2025 | ₹289 Cr | -8.42 | |
| Mar2024 | ₹315 Cr | 14.18 | |
| Mar2023 | ₹276 Cr | 32.02 | |
| Mar2022 | ₹209 Cr | - | |
VIMTA LABS Operating Profit
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 29.68 % |
| 5 Yr CAGR | 23.34 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹122 Cr | 29.68 | |
| Mar2025 | ₹94 Cr | 0.53 | |
| Mar2024 | ₹94 Cr | 17.27 | |
| Mar2023 | ₹80 Cr | 51.40 | |
| Mar2022 | ₹53 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 8.78 % |
| 5 Yr CAGR | 8.91 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 35.45% | 8.78 | |
| Mar2025 | 32.59% | 9.77 | |
| Mar2024 | 29.69% | 2.73 | |
| Mar2023 | 28.9% | 14.68 | |
| Mar2022 | 25.2% | - | |
VIMTA LABS Profit After Tax
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 36.76 % |
| 5 Yr CAGR | 33.12 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹67 Cr | 36.76 | |
| Mar2025 | ₹49 Cr | 3.20 | |
| Mar2024 | ₹47 Cr | 15.20 | |
| Mar2023 | ₹41 Cr | 93.12 | |
| Mar2022 | ₹21 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -1.96 % |
| 5 Yr CAGR | 6.34 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 19.03 % | -1.96 | |
| Mar2025 | 19.41 % | 14.78 | |
| Mar2024 | 16.91 % | 12.66 | |
| Mar2023 | 15.01 % | 0.87 | |
| Mar2022 | 14.88 % | - | |
VIMTA LABS Earnings Per Share (EPS)
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | -42.21 % |
| 5 Yr CAGR | -1.68 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 | -42.21 | |
| Mar2025 | ₹30 | 36.33 | |
| Mar2024 | ₹22 | 3.04 | |
| Mar2023 | ₹21 | 15.08 | |
| Mar2022 | ₹19 | - | |
VIMTA LABS Return on Capital Employed (ROCE)
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | -1.66 % |
| 5 Yr CAGR | 0.99 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 24.81% | -1.66 | |
| Mar2025 | 25.23% | 22.77 | |
| Mar2024 | 20.55% | -15.26 | |
| Mar2023 | 24.25% | 1.68 | |
| Mar2022 | 23.85% | - | |
VIMTA LABS Share Price vs Sensex
| Current Share Price | : | ₹520.2 |
| Current MarketCap | : | ₹ 2,325.3 Cr |
| Updated EOD on | : | Jun 10,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 1.7% |
6.1% |
9.5% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
VIMTA LABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 1% | 1% | 10.4% |
No NSE index found
You may also like the below Video Courses
FAQ about VIMTA LABS Financials
How the annual revenues of VIMTA LABS have changed ?
The Revenues of VIMTA LABS have increased by 19.19% YoY .
How the Earnings per Share (EPS) of VIMTA LABS have changed?
The Earnings Per Share (EPS) of VIMTA LABS has decreased by -42.21 % YoY .
Check out Intrinsic Value of Peers of VIMTA LABS
Compare Stock Analytics of Peers of VIMTA LABS
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
